z-logo
Premium
Effectiveness of intensive practice nurse counselling versus brief general practitioner advice, both combined with varenicline, for smoking cessation: a randomized pragmatic trial in primary care
Author(s) -
Rossem Carolien,
Spigt Mark,
Viechtbauer Wolfgang,
Lucas Annelies E. M.,
Schayck Onno C. P.,
Kotz Daniel
Publication year - 2017
Publication title -
addiction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.424
H-Index - 193
eISSN - 1360-0443
pISSN - 0965-2140
DOI - 10.1111/add.13927
Subject(s) - medicine , abstinence , varenicline , smoking cessation , randomized controlled trial , odds ratio , confidence interval , dosing , pediatrics , emergency medicine , psychiatry , pathology
Aims To study the effectiveness of intensive counselling by a practice nurse (PN) versus brief advice by a general practitioner (GP), each combined with pharmacotherapy, for 6 months’ tobacco abstinence (primary outcome). Secondary outcomes included 12‐month abstinence, medication adherence and incremental costs per life‐year gained. Design A multi‐site ( n  = 10), two‐group, parallel, pragmatic randomized controlled trial. Setting A network of primary health‐care centres in the Netherlands. Participants A total of 295 adult daily smokers (mean age = 48 years; mean cigarettes/day = 19). Intervention and comparator Patients were randomized to receive individual counselling by a practice nurse (PN) ( n  = 149) or brief advice by a general practitioner (GP) (146). All patients received 12 weeks of open‐label varenicline. Measurements The primary outcome was prolonged biochemically validated abstinence from weeks 9 to 26 after treatment initiation. Secondary outcomes included abstinence from weeks 9 to 52, good dosing adherence (> 80% days taken) and incremental costs per life‐year gained. Findings Abstinence rates in the PN versus GP groups were 32.2% ( n  = 48) versus 39.0% [ n  = 57; odds ratio (OR) = 0.71; 95% confidence interval (CI) = 0.44–1.16] from weeks 9 to 26 and 25.5% ( n  = 38) versus 28.8% ( n  = 42; OR = 0.84, 95% CI = 0.50–1.43) from weeks 9 to 52, respectively. Values of the Bayes factor indicated that the PN and GP were equally effective. Good dosing adherence was significantly lower in the PN (45.5%, n  = 56/123) than in the GP group (62.0%, n  = 75/121; OR = 0.45, 95% CI = 0.26–0.77), and the incremental costs per life‐year gained were –€416.10. Conclusions Among people seeking help to stop smoking from their general practice, one‐off brief advice from a general practitioner appears to be as effective as several sessions of behavioural support from a practice nurse when smoking cessation medication is provided.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom